Evidence map›Paper›PMID 32384110›Full record

ArticlePloS one2020

The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach.

Zarifeh Heidary, Jafar Ghaisari, Shiva Moein, Shaghayegh Haghjooy Javanmard

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zarifeh HeidaryDepartment of Electrical and Computer Engineering, Isfahan University of Technology, Isfahan, Iran.
Jafar GhaisariDepartment of Electrical and Computer Engineering, Isfahan University of Technology, Isfahan, Iran.
Shiva MoeinRegenerative Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Shaghayegh Haghjooy JavanmardDepartment of Physiology, Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-3853-5006
Isfahan University of Medical Sciences · IRIsfahan University of Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblasts as key components of tumor microenvironment show different features in the interaction with cancer cells. Although, Normal fibroblasts demonstrate anti-tumor effects, cancer associated fibroblasts are principal participant in tumor growth and invasion. The ambiguity of fibroblasts function can be regarded as two heads of its behavioral spectrum and can be subjected for mathematical modeling to identify their switching behavior. In this research, an agent-based model of mutual interactions between fibroblast and cancer cell was created. The proposed model is based on nonlinear differential equations which describes biochemical reactions of the main factors involved in fibroblasts and cancer cells communication. Also, most of the model parameters are estimated using hybrid unscented Kalman filter. The interactions between two cell types are illustrated by the dynamic modeling of TGFβ and LIF pathways as well as their crosstalk. Using analytical and computational approaches, reciprocal effects of cancer cells and fibroblasts are constructed and the role of signaling molecules in tumor progression or prevention are determined. Finally, the model is validated using a set of experimental data. The proposed dynamic modeling might be useful for designing more efficient therapies in cancer metastasis treatment and prevention.

Indexed as

Models, BiologicalA549 CellsCancer-Associated FibroblastsCell CommunicationChemokine CXCL12Computer SimulationHumansIntercellular Signaling Peptides and ProteinsLeukemia Inhibitory FactorNerve Tissue ProteinsNonlinear DynamicsSignal TransductionSlit Homolog 2 ProteinSystems AnalysisTransforming Growth Factor betaTumor MicroenvironmentChemokine CXCL12CXCL12 protein, humanIntercellular Signaling Peptides and ProteinsLeukemia Inhibitory FactorLIF protein, humanNerve Tissue ProteinsSlit Homolog 2 ProteinTransforming Growth Factor beta

Identifiers

PMID32384110
PMCPMC7209353
OpenAlexW3022862056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.